TMJ Diagnostic Devices Require 510(k) Clearance, Clinical Data – FDA Rule
This article was originally published in The Gray Sheet
Executive Summary
FDA's 11proposed rule on jaw-tracking and dental sonography devices interpreting temporomandibular joint positions or sounds will pave the way for firms to market the products for diagnosing TMJ disorder and associated orofacial pain
You may also be interested in...
Sonogram, Kinesiograph TMD Devices Should Be Class I With 510(k) -Panel
Sonogram and kinesiograph temporomandibular joint (TMJ) devices should be classified as Class I, but are of sufficient concern to warrant submission of a 510(k), FDA's Dental Products Panel unanimously recommended (7-0) at an Aug. 5 meeting.
ELECTROMYOGRAPHS USED IN DIAGNOSING TEMPOROMANDIBULAR DISORDERS
ELECTROMYOGRAPHS USED IN DIAGNOSING TEMPOROMANDIBULAR DISORDERS should be Class III devices, FDA's Dental Products Panel unanimously recommended at an Oct. 13 meeting in Gaithersburg, Maryland. The panel voted 8-0 to recommend that the agency put the devices in Class III and make the call for premarket approval applications on the devices a high priority.
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.